학술논문
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's disease
Document Type
Artikel
Author
Novak, P; Kovacech, B; Katina, S; Schmidt, R; Scheltens, P; Kontsekova, E; Ropele, S; Fialova, L; Kramberger, M; Paulenka-Ivanovova, N; Smisek, M; Hanes, J; Stevens, E; Kovac, A; Sutovsky, S; Parrak, V; Koson, P; Prcina, M; Galba, J; Cente, M; Hromadka, T; Filipcik, P; Piestansky, J; Samcova, M; Prenn-Gologranc, C; Sivak, R; Froelich, L; Fresser, M; Rakusa, M; Harrison, J; Hort, J; Otto, M; Tosun, D; Ondrus, M; Winblad, B; Novak, M; Zilka, N
Source
Nature aging. 1(6):521-534
Subject
Language
English
English
English
ISSN
2662-8465